Literature DB >> 21506017

Cardiovascular manifestations of Alkaptonuria.

Stephen J Pettit1, Michael Fisher, James A Gallagher, Lakshminarayan R Ranganath.   

Abstract

The cardiovascular manifestations of alkaptonuria relate to deposition of ochronotic pigment within heart valves, endocardium, aortic intima and coronary arteries. We assessed 16 individuals with alkaptonuria for cardiovascular disease, including full electrocardiographic and echocardiographic assessment. The self reported prevalence of valvular heart disease and coronary artery disease was low. There was a significant burden of previously undiagnosed aortic valve disease, reaching a prevalence of over 40% by the fifth decade of life. The aortic valve disease was found to increase in both prevalence and severity with advancing age. In contrast to previous reports, we did not find a significant burden of mitral valve disease or coronary artery disease. These findings are important for the clinical follow-up of patients with alkaptonuria and suggest a role for echocardiographic surveillance of patients above 40 years old.

Entities:  

Mesh:

Year:  2011        PMID: 21506017     DOI: 10.1007/s10545-011-9339-z

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  16 in total

1.  BlackAorta: a rare finding at aortic valve replacement.

Authors:  Ross J Goodfellow; Jeffrey Schwartz; Ferdinand Leya
Journal:  J Invasive Cardiol       Date:  2005-03       Impact factor: 2.022

2.  Cardiovascular ochronosis.

Authors:  J J Gaines; G M Pai
Journal:  Arch Pathol Lab Med       Date:  1987-10       Impact factor: 5.534

3.  The molecular basis of alkaptonuria.

Authors:  J M Fernández-Cañón; B Granadino; D Beltrán-Valero de Bernabé; M Renedo; E Fernández-Ruiz; M A Peñalva; S Rodríguez de Córdoba
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

4.  Aortic stenosis and coronary artery disease caused by alkaptonuria, a rare genetic metabolic syndrome.

Authors:  M Vavuranakis; H Triantafillidi; C Stefanadis; P Toutouzas
Journal:  Cardiology       Date:  1998       Impact factor: 1.869

5.  Identification of alkaptonuria in the general population: a United Kingdom experience describing the challenges, possible solutions and persistent barriers.

Authors:  L Ranganath; A M Taylor; A Shenkin; W D Fraser; J Jarvis; J A Gallagher; N Sireau
Journal:  J Inherit Metab Dis       Date:  2011-02-11       Impact factor: 4.982

6.  Cardiac ochronosis: valvular heart disease with dark green discoloration of the leaflets.

Authors:  Ersin Erek; Filip R A Casselman; Hugo Vanermen
Journal:  Tex Heart Inst J       Date:  2004

7.  Aortic valve regurgitation in alkaptonuria.

Authors:  Masaru Yoshikai; Junichi Murayama; Noriko Yamada
Journal:  J Heart Valve Dis       Date:  2004-09

8.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

Authors:  M Lindroos; M Kupari; J Heikkilä; R Tilvis
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

9.  Natural history of alkaptonuria.

Authors:  Chanika Phornphutkul; Wendy J Introne; Monique B Perry; Isa Bernardini; Mark D Murphey; Diana L Fitzpatrick; Paul D Anderson; Marjan Huizing; Yair Anikster; Lynn H Gerber; William A Gahl
Journal:  N Engl J Med       Date:  2002-12-26       Impact factor: 91.245

10.  Ochronosis as an unusual cause of valvular defect: a case report.

Authors:  Andreas Wilke; Dietmar Steverding
Journal:  J Med Case Rep       Date:  2009-11-27
View more
  11 in total

1.  A role for interleukins in ochronosis in a chondrocyte in vitro model of alkaptonuria.

Authors:  J B Mistry; D J Jackson; M Bukhari; A M Taylor
Journal:  Clin Rheumatol       Date:  2015-10-16       Impact factor: 2.980

2.  Fatal methemoglobinemia complicating alkaptonuria (ochronosis): a rare presentation.

Authors:  Amanda R Freeman; Stephen M Wills
Journal:  Forensic Sci Med Pathol       Date:  2018-03-23       Impact factor: 2.007

Review 3.  Alkaptonuria in France: past experience and lessons for the future.

Authors:  Robert Raphael Aquaron
Journal:  J Inherit Metab Dis       Date:  2011-09-17       Impact factor: 4.982

4.  Aortic stenosis and vascular calcifications in alkaptonuria.

Authors:  Hwaida Hannoush; Wendy J Introne; Marcus Y Chen; Sook-Jin Lee; Kevin O'Brien; Pim Suwannarat; Michael A Kayser; William A Gahl; Vandana Sachdev
Journal:  Mol Genet Metab       Date:  2011-10-30       Impact factor: 4.797

Review 5.  [Severe osteoarthritic manifestations of ochronosis].

Authors:  U Lange; U Müller-Ladner; G Dischereit
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

6.  Blackish Pigmentation of the Aorta in Patient with Alkaptonuria and Heyde's Syndrome.

Authors:  Fabio Capuano; Emiliano Angeloni; Antonino Roscitano; Roberto Bianchini; Simone Refice; Andrea Lechiancole; Giovanni Melina; Cosimo Comito; Riccardo Sinatra
Journal:  Aorta (Stamford)       Date:  2014-04-01

7.  Narrowing of the dark valve: aortic stenosis in alkaptonuria.

Authors:  Ketak Nagare; Mohammed Idhrees; Mohammed Ibrahim; Aju Jacob; Bashi Velayudhan
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-10-02

8.  Alkaptonuria--case report.

Authors:  Fernanda Helena Craide; Juliana Salvini Barbosa Martins da Fonseca; Priscila Coelho Mariano; Natalia Monteiro Fernandez; Carlos Gustavo Carneiro de Castro; Yuri de Souza Lima Mene
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

9.  Neurological Assessment and Nerve Conduction Study Findings in 22 Patients with Alkaptonuria from Jordan.

Authors:  Omar Alrawashdeh; Mohammad Alsbou; Hamed Alzoubi; Hani Al-Shagahin
Journal:  Neurol Int       Date:  2017-01-05

10.  Alkaptonuria is a novel human secondary amyloidogenic disease.

Authors:  Lia Millucci; Adriano Spreafico; Laura Tinti; Daniela Braconi; Lorenzo Ghezzi; Eugenio Paccagnini; Giulia Bernardini; Loredana Amato; Marcella Laschi; Enrico Selvi; Mauro Galeazzi; Alessandro Mannoni; Maurizio Benucci; Pietro Lupetti; Federico Chellini; Maurizio Orlandini; Annalisa Santucci
Journal:  Biochim Biophys Acta       Date:  2012-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.